Characteristic | Value |
---|---|
Age | Â |
   Mean | 54.4 ± 10.8 |
Gender | Â |
   Male | 333 (91.5%) |
   Female | 31 (8.5%) |
Primary cancer site | Â |
   Oral cavity | 289 (73.9%) |
   Oropharynx | 47 (12.0%) |
   Hypopharynx | 36 (9.2%) |
   Larynx | 17 (4.4%) |
   Salivary glands | 2 (0.5%) |
Pathological T stage | Â |
   T1 | 80 (20.5%) |
   T2 | 106 (27.1%) |
   T3 | 35 (9.0%) |
   T4 | 162 (41.4%) |
   Biopsy only | 8 (2.0%) |
Pathological N stage | Â |
   N0 | 134 (36.8%) |
   N1 | 62 (17.0%) |
   N2 | 164 (45.1%) |
   N3 | 4 (1.1%) |
p16 status | Â |
   Positive | 8 (2.2%) |
   Negative | 337 (92.6%) |
   Unknown | 19 (5.2%) |
LN status | Â |
   Negative | 375 (48.2%) |
   Metastatic with ENE(-) | 139 (17.9%) |
   Metastatic with ENE(+) | 264 (33.9%) |